These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24059879)

  • 1. Employing resource allocation modeling to inform HIV prevention planning for the state of Iowa.
    Holtgrave DR; Young PA; Mayer RR; Maulsby C; Kim JJ
    AIDS Educ Prev; 2013 Oct; 25(5):423-9. PubMed ID: 24059879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs, consequences and feasibility of strategies for achieving the goals of the National HIV/AIDS strategy in the United States: a closing window for success?
    Holtgrave DR; Hall HI; Wehrmeyer L; Maulsby C
    AIDS Behav; 2012 Aug; 16(6):1365-72. PubMed ID: 22610372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal investment in a portfolio of HIV prevention programs.
    Zaric GS; Brandeau ML
    Med Decis Making; 2001; 21(5):391-408. PubMed ID: 11575489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework.
    Bautista-Arredondo S; Gadsden P; Harris JE; Bertozzi SM
    AIDS; 2008 Jul; 22 Suppl 1():S67-74. PubMed ID: 18664956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic analysis of HIV prevention interventions in Andhra Pradesh state of India to inform resource allocation.
    Dandona L; Kumar SG; Kumar GA; Dandona R
    AIDS; 2009 Jan; 23(2):233-42. PubMed ID: 19112690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV prevention community planning and communities of color: do resources track the epidemic?
    Holtgrave DR; Thomas CW; Chen H; Edlavitch S; Pinkerton SD; Fleming P
    AIDS Public Policy J; 2000; 15(2):75-81. PubMed ID: 11519369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The president's fiscal year 2007 initiative for human immunodeficiency virus counseling and testing expansion in the United States: a scenario analysis of its coverage, impact, and cost-effectiveness.
    Holtgrave DR
    J Public Health Manag Pract; 2007; 13(3):239-43. PubMed ID: 17435490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What works, and what remains to be done, in HIV prevention in the United States.
    Holtgrave DR; Curran JW
    Annu Rev Public Health; 2006; 27():261-75. PubMed ID: 16533117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining allocations for HIV-prevention interventions: assessing a change in federal funding policy.
    Valdiserri RO; Robinson C; Lin LS; West GR; Holtgrave DR
    AIDS Public Policy J; 1997; 12(4):138-48. PubMed ID: 10915267
    [No Abstract]   [Full Text] [Related]  

  • 10. A little planning goes a long way: multilevel allocation of HIV prevention resources.
    Zaric GS; Brandeau ML
    Med Decis Making; 2007; 27(1):71-81. PubMed ID: 17237455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does funding for HIV and sexually transmitted disease prevention matter? Evidence from panel data.
    Chesson HW; Harrison P; Scotton CR; Varghese B
    Eval Rev; 2005 Feb; 29(1):3-23. PubMed ID: 15604117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allocating HIV prevention resources: a tool for state and local decision making.
    Richter A; Hicks KA; Earnshaw SR; Honeycutt AA
    Health Policy; 2008 Sep; 87(3):342-9. PubMed ID: 18342388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some groups question lack of CDC focus on prevention. Main issue: is policy ahead of science and funding?
    AIDS Alert; 2004 Mar; 19(3):25, 27, 30-1. PubMed ID: 15206347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allocating HIV prevention funds in the United States: recommendations from an optimization model.
    Lasry A; Sansom SL; Hicks KA; Uzunangelov V
    PLoS One; 2012; 7(6):e37545. PubMed ID: 22701571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model for allocating CDC's HIV prevention resources in the United States.
    Lasry A; Sansom SL; Hicks KA; Uzunangelov V
    Health Care Manag Sci; 2011 Mar; 14(1):115-24. PubMed ID: 21184183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV/AIDS prevention programs to lose federal funding.
    AIDS Policy Law; 2003 May; 18(9):5. PubMed ID: 12772650
    [No Abstract]   [Full Text] [Related]  

  • 17. Health care policy. U.S. priorities-HIV prevention.
    Catania JA; Morin SF; Canchola J; Pollack L; Chang J; Coates TJ
    Science; 2000 Oct; 290(5492):717. PubMed ID: 11184201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out HIV testing.
    Holtgrave DR
    PLoS Med; 2007 Jun; 4(6):e194. PubMed ID: 17564488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing HIV/AIDS resources in Armenia: increasing ART investment and examining HIV programmes for seasonal migrant labourers.
    Kelly SL; Shattock AJ; Kerr CC; Stuart RM; Papoyan A; Grigoryan T; Hovhannisyan R; Grigoryan S; Benedikt C; Wilson DP
    J Int AIDS Soc; 2016; 19(1):20772. PubMed ID: 27281790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using Resource Allocation Modeling to Inform HIV Prevention Priority Setting for Baltimore-Towson, Maryland.
    Holtgrave DR; Maulsby C; Kim JJ; Cassidy-Stewart H; Hauck H
    Prog Community Health Partnersh; 2016; 10(1):133-9. PubMed ID: 27018362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.